A detailed history of True Mark Investments, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, True Mark Investments, LLC holds 29,751 shares of ABBV stock, worth $6.11 Million. This represents 1.69% of its overall portfolio holdings.

Number of Shares
29,751
Previous 5,327 458.49%
Holding current value
$6.11 Million
Previous $1.05 Billion 402.55%
% of portfolio
1.69%
Previous 0.34%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$164.99 - $203.87 $4.03 Million - $4.98 Million
24,424 Added 458.49%
29,751 $5.29 Billion
Q3 2024

Oct 15, 2024

SELL
$163.84 - $199.33 $98,140 - $119,398
-599 Reduced 10.11%
5,327 $1.05 Billion
Q2 2024

Jul 29, 2024

BUY
$154.79 - $180.76 $917,285 - $1.07 Million
5,926 New
5,926 $1.02 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $363B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track True Mark Investments, LLC Portfolio

Follow True Mark Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of True Mark Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on True Mark Investments, LLC with notifications on news.